LongeVC is launching its second fund targeting $250 million, as the global venture capital (VC) firm looks to explore more opportunities in Asia to grow its portfolio of biotech and longevity-focused companies.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
